Severe Decrease of Growth Velocity in Children With Anorexia Nervosa. Therapeutic Trial of Growth Hormone
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Somatrogon (Primary)
- Indications Anorexia nervosa; Growth disorders
- Focus Therapeutic Use
- 01 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 14 Jan 2016 Planned end date changed from 1 Sep 2016 to 1 Mar 2022, as reported by ClinicalTrials.gov.
- 14 Jan 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Mar 2022, as reported by ClinicalTrials.gov.